Pomalyst (Pomalidomide; Celgene) Drug Overview 2017-2026 - ResearchAndMarkets.com

DUBLIN--()--The "Pomalyst" report has been added to ResearchAndMarkets.com's offering.

Pomalyst (pomalidomide; Celgene) is an oral class I thalidomide analog, immunomodulatory drug with antineoplastic activity.

In vitro studies have shown that the drug acts through multiple mechanisms. Evidence suggests that in addition to anti-angiogenic effects, Pomalyst inhibits proliferation and induces apoptosis of hematopoietic tumor cells, and may have antineoplastic effects.

Pomalyst also enhanced T cell- and natural killer cell-mediated immunity and inhibited production of pro-inflammatory cytokines by monocytes.

Key Topics Covered

  1. Drug Overview
  2. Product Profiles
  3. Pomalyst : Multiple myeloma

LIST OF FIGURES

Figure 1: Pomalyst for multiple myeloma - SWOT analysis

Figure 2: The authors drug assessment summary of Pomalyst for multiple myeloma

Figure 3: The authors drug assessment summary of Pomalyst for multiple myeloma

Figure 4: Pomalyst sales for multiple myeloma across the US, Japan, and five major EU markets, by country, 2017-26

LIST OF TABLES

Table 1: Pomalyst drug profile

Table 2: Pomalyst pivotal trial data in multiple myeloma

Table 3: Pomalyst late-phase trial data in multiple myeloma

Table 4: Pomalyst key ongoing clinical trials in multiple myeloma

Table 5: Pomalyst sales for multiple myeloma across the US, Japan, and five major EU markets, by country ($m), 2017-26

Table 6: Patients treated with Pomalyst across the US, Japan, and five major EU markets, by country, 2017-26

For more information about this report visit https://www.researchandmarkets.com/r/u23j7b

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Related Topics: Leukemia Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Related Topics: Leukemia Drugs